IQVIA™ Real-World Insights Bibliography

Real-world insights on the management of migraine patients: an Italian nationwide study
Author(s): Agostoni E1, Barbanti P2, Frediani F3, Trifir? G4, Burgio L5, di Nola L5, Pegoraro V6, Pulimeno S5, Cepparulo M5
Affiliations(s): 1 Neurology and Stroke Unit, Department of Neurosciences, Niguarda Neuro Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy 2 Headache and Pain Unit, Department of Neurological, Motor and Sensorial Sciences, IRCCS San Raffaele Pisana, Rome, Italy - San Raffaele University, Rome, Italy 3 Headache Center, Neurology and Stroke Unit Division, S. Carlo Borromeo Hospital, ASST Santi Paolo e Carlo, Milan, Italy 4 Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy 5 TEVA Italia Srl, Milan, Italy 6 IQVIA, Milan, Italy
Publication(s):  Curr Med Res Opin. 2019 Mar 29:1-10
Document Type(s): Article,
Countries: Italy,
C:
Y:
Neurological disorders, Pain,
2019
  L:
A:
English
Database Study, Epidemiological study, Observational study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis,
  Add to report
 
 
Economic evaluation of cladribine tablets in relapsing multiple sclerosis (RMS) patients with high disease activity (HAD) in lebanon
Author(s): Metni M1, Yamout B2, Koussa S3, Khamis C3, Fleifel L4, Sharifi S4, Mohamed O5
Affiliations(s): 1National Social Security Fund, Beirut, NJ, Lebanon, 2American University if Beirut, Beirut, NJ, Lebanon, 3Geitaoui hospital, Beirut, Lebanon, 4Merck Serono Middle East FZ-Ltd, an affiliate of Merck KGaA, Dubai, 07, United Arab Emirates, 5IQVIA, Dubai, NJ, United Arab Emirates
Publication(s):  2019-11, ISPOR Europe 2019, Copenhagen, Denmark
Document Type(s): Poster,
Countries: Lebanon,
Click here for the abstract
C:
Y:
Neurological disorders,
2019
  L:
A:
English
Budget impact, Cost utility,
  Add to report
 
 
Cost effectiveness of cladribine tablets for treatment of RRMS in the Netherlands
Author(s): de Francesco M1, Mahajan K2, Michels RE3, Schiffers K4, Budhia S5, Harty G6, Krol M3
Affiliations(s): 1IQVIA, Zaventem, Belgium, 2IQVIA, Gurgaon, India, 3IQVIA, Amsterdam, The Netherlands, 4Merck B.V., an affiliate of Merck KGaA, Schiphol-Rijk, The Netherlands, 5PAREXEL International, Waltham, MA, USA, 6EMD Serono, Billerica, MA, USA
Publication(s):  2018-11, ISPOR Europe 2018, Barcelona, Spain
Document Type(s): Article,
Countries: Netherlands,
Click here for the abstract
C:
Y:
Neurological disorders,
2019
  L:
A:
English
Cost effectiveness, Predictive analytics,
  Add to report
 
 
Pregnancy and Infant Outcomes with Interferon Beta: Data from the European Interferon Beta Pregnancy Registry and MS Pregnancy study conducted in Finland and Sweden
Author(s): "Kerstin Hellwig*, Yvonne Geissbuehler2, Meritxell Sabidó3, Catrinel Popescu4, Alessandra Adamo5, Joachim Klinger6, Peter Huppke7, Asher Ornoy8, Pasi Korhonen9, Kjell-Morten Myhr10, Scott Montgomery11, Sarah Burkill11, European Interferon Beta Pregnancy Study Group"
Affiliations(s): *Katholisches Klinikum Bochum, St Josef-Hospital Universitatsklinikum, Bochum, Germany; 9StatFinn & EPID Research, Espoo, Finland
Publication(s):  AAN, Philadelphia, USA, 4-10 May 2019
Document Type(s): Oral presentation,
Countries: Europe, Finland, Sweden,
Click here for the abstract
C:
Y:
Neurological disorders,
2019
  L:
A:
English
Epidemiological study, Population Based Study,
  Add to report
 
 
No increased risk of spontaneous abortion and ectopic pregnancy after exposure to interferon-beta prior to or during pregnancy: Results from register-based Nordic study among women with MS
Author(s): R. Juuti1, K. M. Hakkarainen 1, S. Burkill 2, Y. Geissbuehler 3, M. Sabidó 4, C. Popescu 5, A. Adamo 6, J. Hillert 2, S. Cnattingius 2, M. Artama 7, A. Verkkoniemi-Ahola 8, K.-M. Myhr 9, J. Mehtälä 1, S. Bahmanyar 2, S. Montgomery 2,10, P. Korhonen 1 and the European Interferon Beta Pregnancy Study Group
Affiliations(s): 1StatFinn-EPID Research, Espoo, Finland
Publication(s):  EAN, Oslo, Norway, June 29-2 July, 2019
Document Type(s): Oral presentation,
Countries: Finland, Germany, Norway, Sweden, Switzerland, UK,
Click here for the abstract
C:
Y:
Neurological disorders,
2019
  L:
A:
English
Epidemiological study, Population Based Study, Retrospective database analysis,
  Add to report
 
 
Prevalence of infant outcomes at birth after exposure to interferon beta prior to or during pregnancy: A register-based cohort study in Finland and Sweden among women with MS
Author(s): Pia Vattulainen1, Sarah Burkill2, Yvonne Geissbuehler3, Meritxell Sabidó4, Catrinel Popescu5, Kiliana Suzart-Woischnik6, Kjell-Morten Myhr7, Scott Montgomery2,8, Pasi Korhonen1 the European Interferon Beta Pregnancy Study Group and the Nordic MS Pregnancy & Interferon Beta study group
Affiliations(s): 1StatFinn-EPID Research, Espoo, Finland
Publication(s):  ECTRIMS, Stockholm, Sweden, 11-13 September, 2019
Document Type(s): Poster,
Countries: Finland, Sweden,
Click here for the abstract
C:
Y:
Neurological disorders,
2019
  L:
A:
English
Epidemiological study, Population Based Study, Retrospective cohort analysis,
  Add to report
 
 
Characterization of preventive treatment in episodic and chronic migraine patients managed by general practitioners in Italy
Author(s): Pegoraro V1, Heiman F1, di Nola L2, Pulimeno S2, Burgio L2
Affiliations(s): 1 IQVIA, RWI, Milan, Italy 2 Teva Italia Srl, Assago, Milan, Italy
Publication(s):  ISPOR 21st Annual European Congress, 10-14 November 2018, Barcelona, Spain
Document Type(s): Poster,
Countries: Italy,
C:
Y:
Neurological disorders, Pain,
2018
  L:
A:
English
Database Study, Epidemiological study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis,
  Add to report
 
 
Diagnoses of Dizziness- and Vertigo-Related in ENT Practices in Germany
Author(s): Seidel DU, Park JJH, Sesterhenn AM, Kostev K
Affiliations(s): 
Publication(s): 
Document Type(s): Article,
Countries: Germany,
C:
Y:
Mental health, Neurological disorders,
2018
  L:
A:
English
  Add to report
 
 
Diagnosis and Treating Dementia in German Primary and Specialized Care Between 2011 and 2015
Author(s): Michalowsky B, Kostev K, Iliffe S, Hoffmann W, Bohlken J
Affiliations(s): 
Publication(s):  INT J CLIN PHARMACOL THER. 2018 APR 27.
Document Type(s): Article,
Countries: Germany,
C:
Y:
Mental health, Neurological disorders,
2018
  L:
A:
English
  Add to report
 
 
The Influence of Polypharmacy on the Initiation of Anti-Dementia Therapy in Germany
Author(s): Bohlken J, Jacob L, Van Den Bussche H, Kostev K
Affiliations(s): 
Publication(s):  J ALZHEIMERS DIS. 2018 JUN 6.
Document Type(s): Article,
Countries: Germany,
C:
Y:
Mental health, Neurological disorders,
2018
  L:
A:
English
  Add to report
 
 
 1 of 21 Next Page Last Page